Administration of activated charcoal or sodium polystyrene sulfonate (Kayexalate) as gastric decontamination for lithium intoxication: an animal model.
暂无分享,去创建一个
A. Woolf | W. Lewander | J. Driscoll | J. Linakis | P. Lacouture | T. Maher | M. Eisenberg | Timothy J. Maher | James G. Linakis | P. G. Lacouture | William J. Lewander | James L. Driscoll | Alan D. Woolf
[1] R. Spector,et al. Enhancement of theophylline clearance by oral activated charcoal , 1983, Clinical pharmacology and therapeutics.
[2] R. Spector,et al. Acceleration of the body clearance of phenobarbital by oral activated charcoal. , 1982, The New England journal of medicine.
[3] B. Gumbiner,et al. Lithium carbonate intoxication. A case report and review of the literature. , 1989, Archives of internal medicine.
[4] G. Oderda,et al. In vitro study of lithium carbonate adsorption by activated charcoal. , 1988, Journal of toxicology. Clinical toxicology.
[5] S. Pond. Role of Repeated Oral Doses of Activated Charcoal in Clinical Toxicology , 1986, Medical toxicology.